Trending - Altmetric
- Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple MyelomaLast mentioned on Thu May 20 2021
- Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Nonmalignant Clonal HematopoiesisLast mentioned on Mon May 31 2021
- PML/RARa Destabilization by Hyperthermia: A New Model for Oncogenic Fusion Protein Degradation?Last mentioned on Wed May 19 2021
- Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in HealthcareLast mentioned on Tue May 18 2021
- Hyperthermia Selectively Destabilizes Fusion OncoproteinsLast mentioned on Thu Jun 03 2021
- Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic MalignanciesLast mentioned on Wed Jun 09 2021
- Honoring Emil J. Freireich: A Visionary Medical Cancer Researcher—March 21, 1927–February 1, 2021Last mentioned on Tue Jun 08 2021
- Finding the Optimal Partner to Pair with Bispecific Antibody Therapy for Multiple MyelomaLast mentioned on Sat Jun 05 2021
- An Evolutionary Approach to Clonally Complex Hematologic DisordersLast mentioned on Wed Jun 09 2021
- Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDSLast mentioned on Thu Jun 10 2021
- SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid LeukemiaLast mentioned on Sun Jun 06 2021
- Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin LymphomaLast mentioned on Mon May 24 2021
- Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapyLast mentioned on Mon Jun 07 2021
- Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapyLast mentioned on Thu May 27 2021
- Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood CancersLast mentioned on Tue May 25 2021
- Bortezomib Induces Immunogenic Cell Death in Multiple MyelomaLast mentioned on Thu May 27 2021
- Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activationLast mentioned on Thu May 27 2021
- Toward Artificial Intelligence–Driven Pathology Assessment for Hematologic MalignanciesLast mentioned on Mon May 24 2021
- A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase–Deficient Cells in Myeloid NeoplasmsLast mentioned on Wed Jun 09 2021
- Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 InhibitorsLast mentioned on Tue May 18 2021
- Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic LeukemiaLast mentioned on Tue May 18 2021
- Non-oncogene Addiction to SIRT5 in Acute Myeloid LeukemiaLast mentioned on Tue Jun 01 2021
- Toward More Complete Prognostication for Patients with Clonal HematopoiesisLast mentioned on Thu Jun 03 2021